Pharmacotherapy of Obesity: Options and Alternatives
Autor Karl G. Hofbauer, Ulrich Keller, Olivier Bossen Limba Engleză Hardback – 14 iun 2004
Toate formatele și edițiile | Preț | Express |
---|---|---|
Paperback (1) | 535.80 lei 6-8 săpt. | |
CRC Press – 23 sep 2019 | 535.80 lei 6-8 săpt. | |
Hardback (1) | 1528.57 lei 6-8 săpt. | |
CRC Press – 14 iun 2004 | 1528.57 lei 6-8 săpt. |
Preț: 1528.57 lei
Preț vechi: 1609.02 lei
-5% Nou
Puncte Express: 2293
Preț estimativ în valută:
292.63€ • 304.17$ • 242.62£
292.63€ • 304.17$ • 242.62£
Carte tipărită la comandă
Livrare economică 06-20 februarie 25
Preluare comenzi: 021 569.72.76
Specificații
ISBN-13: 9780415303217
ISBN-10: 0415303214
Pagini: 504
Ilustrații: 70 b/w images
Dimensiuni: 178 x 254 x 32 mm
Greutate: 1.02 kg
Ediția:New.
Editura: CRC Press
Colecția CRC Press
ISBN-10: 0415303214
Pagini: 504
Ilustrații: 70 b/w images
Dimensiuni: 178 x 254 x 32 mm
Greutate: 1.02 kg
Ediția:New.
Editura: CRC Press
Colecția CRC Press
Public țintă
Professional ReferenceCuprins
Primarily intended for physicians and health care professionals who are treating obese patients, this book explores current and future options for drug treatment of obesity puts them into perspective against available alternative treatments. Distinguished scientists and clinical investigators provide reviews of each individual topic, covering a wide range of subjects from pathophysiology of obesity to the benefits of weight loss. The core sections on pharmacotherapy deal with currently available drugs and drugs in pre-clinical development, complemented with sections on non-drug treatment and general therapeutic aspects to provide an integrated view of therapeutic approaches to the treatment of obesity and its associated syndromes.
Notă biografică
Hofbauer, Karl G.; Keller, Ulrich; Boss, Olivier
Descriere
This book provides an essential, all-around view of the treatment of obesity for anyone involved in obesity management, whether clinical or research-based, and for researchers in pharmacology, physiology, or the pharmaceutical industry.